Patients receiving modern immunotherapy for metastatic renal cell carcinoma have a decreased risk of death if they also undergo cytoreductive nephrectomy, a study found.
Next-generation sequencing is being increasingly used to characterize the diversity of T-cell and B-cell receptors in individuals.
Hazard ratio 0.44 for incident cancer with loss of at least 20 to 35 versus <20% of total body weight.
The highest vs lowest quartile of vitamin D binding protein was associated with 4.1-fold increased odds of renal cell carcinoma in adjusted analyses.
Microwave ablation for cT1b renal cell carcinoma has outcomes that compare favorably with partial and radical nephrectomy, a study found.
The method could more accurately classify patients with clear cell disease.
Overall cancer incidence and mortality for kidney and other cancers up with severe psoriasis.
The use of steroids for the treatment of immune-related adverse events may have survival consequences.
Following nephrectomy for renal cell carcinoma with lymph node involvement, patients have a 5-year survival rate of only 28%, a new study found.
Updated follow-up of patients in the KEYNOTE-427 trial showed that first-line pembrolizumab for advanced clear cell renal cell carcinoma exerts favorable antitumor activity after a median 23 months of follow-up.